6JIJ
The Crystal Structure of Main Protease from Mouse Hepatitis Virus A59 in Complex with an inhibitor
Summary for 6JIJ
Entry DOI | 10.2210/pdb6jij/pdb |
Related PRD ID | PRD_002214 |
Descriptor | Replicative polyprotein 1ab, 02J-ALA-VAL-LEU-PJE-010 (3 entities in total) |
Functional Keywords | main protease, mouse hepatitis virus a59, hydralase-inhibitor complex, hydralase/inhibitor |
Biological source | Murine coronavirus (strain A59) (MHV-A59) More |
Total number of polymer chains | 6 |
Total formula weight | 101221.46 |
Authors | |
Primary citation | Cui, W.,Cui, S.,Chen, C.,Chen, X.,Wang, Z.,Yang, H.,Zhang, L. The crystal structure of main protease from mouse hepatitis virus A59 in complex with an inhibitor. Biochem. Biophys. Res. Commun., 511:794-799, 2019 Cited by PubMed Abstract: Mouse hepatitis virus A59 (MHV-A59) is a representative member of the genus betacoronavirus within the subfamily Coronavirinae, which infects the liver, brain and respiratory tract. Through different inoculation routes, MHV-A59 can provide animal models for encephalitis, hepatitis and pneumonia to explore viral life machinery and virus-host interactions. In viral replication, non-structural protein 5 (Nsp5), also termed main protease (M), plays a dominant role in processing coronavirus-encoded polyproteins and is thus recognized as an ideal target of anti-coronavirus agents. However, no structure of the MHV-A59 M has been reported, and molecular exploration of the catalysis mechanism remains hindered. Here, we solved the crystal structure of the MHV-A59 M complexed with a Michael acceptor-based inhibitor, N3. Structural analysis revealed that the Cβ of the vinyl group of N3 covalently bound to C145 of the catalytic dyad of M, which irreversibly inactivated cysteine protease activity. The lactam ring of the P1 side chain and the isobutyl group of the P2 side chain, which mimic the conserved residues at the same positions of the substrate, fit well into the S1 and S2 pockets. Through a comparative study with M of other coronaviruses, we observed that the substrate-recognition pocket and enzyme inhibitory mechanism is highly conservative. Altogether, our study provided structural features of MHV-A59 M and indicated that a Michael acceptor inhibitor is an ideal scaffold for antiviral drugs. PubMed: 30833083DOI: 10.1016/j.bbrc.2019.02.105 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.65 Å) |
Structure validation
Download full validation report
